Results 251 to 260 of about 89,131 (302)
Some of the next articles are maybe not open access.

Pneumonia in the Immunocompromised Host

Seminars in Roentgenology, 2022
Pneumonia in the immunocompromised host can be devastating and can result from both common and opportunistic organisms. This paper examines the imaging findings in mostly opportunistic organisms which cause pneumonia in the immunocompromised host. Some organisms, such as tuberculosis, non-tuberculous mycobacteria, and influenza will also be discussed ...
Sowmiya, Murali   +4 more
openaire   +2 more sources

Immunocompromised Hosts

2019
Abstract Infections in immunocompromised patients may occur in the clinical setting of neutropenia, B-cell and T-cell deficiencies, immunoglobulin deficiencies, complement deficiencies, and leukocyte dysfunction. Some patients have multiple defects due to both the underlying disease and its treatment.
Elena Beam   +2 more
openaire   +1 more source

Lung biopsy in immunocompromised hosts

The American Journal of Medicine, 1975
Ninety-five lung biopsy procedures in 78 immunocompromised patients yielded treatable diagnoses in 35 per cent of the needle aspirates, 46 per cent of the cutting needle biopsies and 65 per cent of the open thoracotomies. Complication rates of bleeding or pneumothorax were comparable to those previously described in nonimmunocompromised patients.
R L, Greenman, P T, Goodall, D, King
openaire   +2 more sources

Musculoskeletal Infections in Immunocompromised Hosts

Orthopedic Clinics of North America, 1991
Infection of the skeletal system in immunocompromised hosts is a legitimate concern. Indolent presentations and unusual pathogens are more common among impaired hosts. Delays in diagnosis may lead to joint destruction and disability. Accurate diagnosis requires specific requests for the microbiology laboratory to plate specimens onto fungal ...
P J, Brennan, M P, DeGirolamo
openaire   +2 more sources

Antimicrobial Stewardship in Immunocompromised Hosts

Infectious Disease Clinics of North America, 2014
The global spread of antimicrobial resistance has limited the availability of antimicrobial agents to treat infections that affect immunocompromised hosts. Efforts to optimize the selection, dosing, and duration of antimicrobial therapy to improve patient outcomes and minimize selective pressure on antimicrobial resistance are relevant to ...
Lilian M, Abbo, Ella J, Ariza-Heredia
openaire   +2 more sources

Vaccination of the immunocompromised host

Wiener Medizinische Wochenschrift, 2004
Vaccinations are safe and effective in immunocompromised patients. Apparently most vaccines in this patient population are underutilized. General vaccination recommendations are expressed for influenza, diphtheria and tetanus. Pneumococcal, meningococcal und Haemophilus influenzae B immunizations are specially indicated for patients with or developing ...
Andrew J, Ullmann   +2 more
openaire   +2 more sources

Gastrointestinal mucormycosis in immunocompromised hosts

Mycoses, 2015
SummaryInvasive mucormycosis is a rare fungal infection in immunocompromised hosts, but it carries a high mortality rate. Primary gastrointestinal disease is the least frequent form of presentation. Early diagnosis and treatment are critical in the management; however, symptoms are typically non‐specific in gastrointestinal disease, leading to delayed ...
M Veronica, Dioverti   +5 more
openaire   +2 more sources

Travel and the immunocompromised host

Hospital Medicine, 2000
Increasing opportunities for travel and advances in medicine mean that immunocompromised patients may venture to potentially risky parts of the world. This article examines the risks faced by such travellers. Some limitations of standard travel vaccines are discussed and suggestions are made as to how best to advise such travellers.
openaire   +2 more sources

Infection in the immunocompromised host

The Pediatric Infectious Disease Journal, 1985
The largest numbers of immunocompromised pediatric patients are neonates and children who are managed in intensive care units. Therapeutic principles that apply to the classic neutropenic cancer patient are also relevant for these categories; maximum doses of bactericidal antibiotics given for longer periods should be used. Pediatricians should also be
openaire   +3 more sources

The Immunocompromised Host

1990
An immunocompromised host is an individual whose immune defense mechanisms are impaired. This may be due to decreased antibody formation (B lymphocyte function), cell-mediated immunity (T lymphocyte function), granulocyte function, or a combination of these.
openaire   +1 more source

Home - About - Disclaimer - Privacy